See All Slides -

Slides

Presentation TCT 2012

Synthesis of the New ESC LAA Closure Guidelines

Presenter: Peter Sick

October 23, 2012

Presentation TCT 2012

VESTAsync (MIV Therapeutics) Program Update

Presenter: Ricardo Costa

October 23, 2012

Presentation TCT 2012

Nanoparticle-Based Stents 2: FOCUS np (Envision Scientific) Program Update

Presenter: Ashok Seth

October 23, 2012

Presentation TCT 2012

TCT-18. Long-term Outcome of Discordance Between Fractional Flow Reserve and Coronary Flow Velocity Reserve After Deferral of Percutaneous Coronary Intervention

Presenter: Tim van de Hoef

October 23, 2012

Presentation TCT 2012

State-of-the-Field Keynote: The Next Challenge: Improving Technical Efficiency and Biological Response (Nonresponders)

Presenter: Deepak Bhatt

October 23, 2012

Presentation TCT 2012

TCT-103. The Transaortic Approach for Transcatheter Aortic Valve Replacement: Initial Clinical Experience in the United States

Presenter: Joel Lardizabal

October 23, 2012

Presentation TCT 2012

TCT-585: Six-Month Results of the BIOLUX P-I First-in-Man Study Comparing a Paclitaxel-Releasing Balloon Catheter vs. an Uncoated Balloon Catheter in Femoropopliteal Lesions

Presenter: Dierk Scheinert

October 23, 2012

Presentation TCT 2012

Introduction(6)

Presenter: Rudiger Lange

October 23, 2012

Presentation TCT 2012

Management of the Device Patient for the Non-EP MD

Presenter: Ralph Verdino

October 23, 2012

Presentation TCT 2012

Introduction(11)

Presenter: Biykem Bozkurt

October 23, 2012

Advertisement

Slides

Synthesis of the New ESC LAA Closure Guidelines

VESTAsync (MIV Therapeutics) Program Update

Nanoparticle-Based Stents 2: FOCUS np (Envision Scientific) Program Update

TCT-18. Long-term Outcome of Discordance Between Fractional Flow Reserve and Coronary Flow Velocity Reserve After Deferral of Percutaneous Coronary Intervention

State-of-the-Field Keynote: The Next Challenge: Improving Technical Efficiency and Biological Response (Nonresponders)

TCT-103. The Transaortic Approach for Transcatheter Aortic Valve Replacement: Initial Clinical Experience in the United States

TCT-585: Six-Month Results of the BIOLUX P-I First-in-Man Study Comparing a Paclitaxel-Releasing Balloon Catheter vs. an Uncoated Balloon Catheter in Femoropopliteal Lesions

Introduction(6)

Management of the Device Patient for the Non-EP MD

Introduction(11)

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content